Cargando…
Bioprosthetic vs. Mechanical Mitral Valve Replacement for Rheumatic Heart Disease in Patients Aged 50–70 Years
BACKGROUND: Rheumatic heart disease (RHD) is a critical problem in developing countries and is the cause of most of the cardiovascular adverse events in young people. In patients aged 50–70 years with RHD requiring mitral valve replacement (MVR), deciding between bioprosthetic and mechanical prosthe...
Autores principales: | Yu, Jun, Wang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9193579/ https://www.ncbi.nlm.nih.gov/pubmed/35711344 http://dx.doi.org/10.3389/fcvm.2022.904958 |
Ejemplares similares
-
Transcatheter Valve-in-Valve Procedures for Bioprosthetic Valve Dysfunction in Patients With Rheumatic vs. Non-Rheumatic Valvular Heart Disease
por: Lopes, Mariana Pezzute, et al.
Publicado: (2021) -
Mitral Valve Surgery in Patients With Rheumatic Heart Disease: Repair vs. Replacement
por: Fu, Guangguo, et al.
Publicado: (2021) -
Transseptal Transcatheter Mitral Valve-in-valve Replacement for a Failed Bioprosthetic Mitral Valve
por: Kang, Do-Yoon, et al.
Publicado: (2018) -
Bioprosthetic Heart Valves: Upgrading a 50-Year Old Technology
por: Li, Kan Yan Chloe
Publicado: (2019) -
Bioprosthetic vs mechanical mitral valve replacement for infective endocarditis in patients aged 50 to 69 years
por: Hu, Xingjian, et al.
Publicado: (2020)